PolyBioMed Limited, Lombard Medical Technologies, Sheffield, UK.
Biography
Kadem Al-Lamee, CEO, Arterius Limited, was a co-founder of PolyBioMed Limited in 1996, serving as Technical Director before becoming Managing Director in 2001, when PolyBioMed was acquired by Lombard Medical Technologies. PolyBioMed was recently purchased by Bayer Materials Science. Dr Al-Lamee was integral to the development of the businessthroughout its history, including strategic development, fund-raising, technical development and the establishment of its intellectual property portfolio. Previously he was Principal Scientist in polymer chemistry for Innovative Technologies plc, managing research and development programmes in areas including wound dressings and coated urinary catheters.
+44 1300 500008